Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clearside Biomedical Inc.

www.clearsidebio.com

Latest From Clearside Biomedical Inc.

Clearside Says Uveitis Indication For Xipere Would Keep Company Afloat

Following failure and discontinuation of Phase III studies in retinal vein occlusion, company says it will have enough cash to get through 2020.

Research & Development Ophthalmic

Pipeline Watch: Top-line Phase III Results For KX2-391, Dasotraline And Brigatinib

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Pipeline Watch Approvals

Pipeline Watch: Phase III Progress With Semaglutide, Tecentriq And Epidaza

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Pipeline Watch Approvals

Appointments: Nordic Nanovector Loses CEO, Verona Pharma Loses CMO, Plus New CEOs At DalCor And PureTech Health

This week's announcements include two CEO resignations at Nordic Nanovector and Verona Pharma, new CEOs at DalCor Pharmaceuticals and PureTech Health, new CMOs at Medigene, Argenx, Pneuma Respiratory and ReNeuron, plus board appointments.

Appointments BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Surgical Equipment & Devices
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Clearside Biomedical Inc.
  • Senior Management
  • George Lasezkay, Interim CEO
    Charles A Deignan, CFO
    Rick McElheny, VP, Corp. Dev.
    Brion Raymond, Chief Commercial Officer
    Thomas A Ciulla, MD, CMO
  • Contact Info
  • Clearside Biomedical Inc.
    Phone: (678) 270-3631
    900 North Point Pkwy., Ste. 200
    Alpharetta, GA 30005
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register